Companies /Healthcare
Envista Holdings Corp
NYSE: NVST Medical Instruments & Supplies
$25.32
▼ $0.52 (−2.01%) today
Markets closed · 11:55pm ET

Envista (NVST) Q3 2026 Earnings

Reported Nov 4, 2026, 4:05pm ET
$0.40
Beat +12.36%
EPS · est. $0.36 Adjusted

GAAP diluted EPS of $3.11 includes a $428.1 million non-cash realized cumulative foreign currency translation gain ($2.62 per diluted share before tax effects); adjusted results also exclude $15.6 million of tariff refunds ($0.10 per share) and a $7.6 million loss on equity investments ($0.05 per share)

$691.5M
Beat +0.40%
Revenue · est. $688.7M
6 quarters
Consecutive EPS beats

How Did NVST Stock React to Q3 2026 Earnings?

% change · around the report
0+3%+6%Nov 3Nov 11report 4:05pm ETearnings+0.2%+2.2%
0+3%+6%Nov 3Nov 11earnings+0.2%+2.2%
NVST +2.2%S&P 500 +0.2%
−3%0+3%+6%Nov 3Nov 11report 4:05pm ETearnings−0.5%+2.2%
−3%0+3%+6%Nov 3Nov 11earnings−0.5%+2.2%
NVST +2.2%NASDAQ −0.5%
−8.20%
Day of report
+0.84%
Next session

Did NVST Beat Earnings? Q3 2026 Results

Yes. Envista reported Q3 2026 earnings of $0.40 a share on Nov 4, 2026, beating the $0.36 consensus estimate by 12.4%. Revenue was $691.5M against a $688.7M estimate.

Envista Holdings Corporation posted a solid third-quarter 2026 beat on both the top and bottom lines, extending its streak of beating consensus EPS estimates to five consecutive quarters. The dental products company reported adjusted diluted EPS of $0.40, clearing the $0.36 analyst consensus by 12.36%, while revenue of $691.50 million edged past the $688.73 million estimate and grew 3.2% year over year. The key engine behind the profitability gains was margin expansion driven by the Envista Business System, with adjusted operating margin widening to 13.7% from 12.8% a year ago and adjusted EBITDA margin improving 80 basis points to 15.3%. Core sales grew 2.7%, with the Equipment and Consumables segment leading the way at 4.1% core growth. GAAP net income swung to $508.30 million from a prior-year loss of $30.30 million, though that figure was heavily influenced by a non-cash $428.10 million foreign currency translation gain tied to legal entity simplification efforts. Looking ahead, management lifted full-year adjusted diluted EPS guidance to $1.54 to $1.58 and narrowed core sales growth expectations to 3.75% to 4.25%, signaling continued confidence in the company's trajectory.

Key Takeaways
  • Core sales growth of 2.7%, with 2.0% in Specialty Products & Technologies and 4.1% in Equipment & Consumables
  • Envista Business System contributions drove 20 bps adjusted gross margin expansion and 80 bps adjusted EBITDA margin expansion
  • Equipment & Consumables adjusted operating margin rose to 22.4% from 20.1%
  • Share gains cited by CEO
  • Lower diluted share count from repurchases

“Envista delivered another quarter of profitable growth, gaining share and expanding margins.”

Envista CEO, on the earnings call

What Is Envista's Outlook?

Envista raised its full-year 2026 guidance. It now expects core sales growth of 3.75% to 4.25% (prior 3.5% to 4.5%) and adjusted EBITDA growth of 12.5% to 14% (prior 11% to 14%). Adjusted diluted EPS guidance is $1.54 to $1.58 (prior $1.50 to $1.55). Free cash flow conversion guidance remains approximately 100%. The company does not provide GAAP forward-looking estimates.

NVST YoY Financials

Q3 2026 vs Q3 2025 · SEC filings Q3 2025 Q3 2026
$0$200.0M$400.0M$600.0M$669.9M$691.5MRevenue$375.1M$400.6MGross Profit$64.8M$515.2MOperating Income$27.1M$508.3MNet Income
$0$200.0M$400.0M$600.0MRevenueGross ProfitOperating IncomeNet Income
NVST income statement, Q3 2026 versus Q3 2025
Metric Q3 2026 Q3 2025 Year over year
Revenue $691.5M $669.9M +3.2%
Gross Profit $400.6M $375.1M +6.8%
Operating Income $515.2M $64.8M +695.1%
Net Income $508.3M $27.1M +1,777.6%

NVST Revenue by Segment

Specialty Products & Technologies$443.7M+2.8%
Equipment & Consumables$247.8M+3.9%

When Does Envista Report Next?

Expected report date
After the close
Release timing

Figures from SEC filings and company reports. Not investment advice.